Contact: Nick Zagorski
[email protected]
301-634-7366
American Society for Biochemistry and Molecular Biology
For fats, longer may not be better
Appearing in the January issue of JLR
Researchers
have uncovered why some dietary fats, specifically long-chain fats,
such as oleic acid (found in olive oil), are more prone to induce
inflammation. Long-chain fats, it turns out, promote increased
intestinal absorption of pro-inflammatory bacterial molecules called
lipopolysaccharides (LPS). This study appears in the January issue of
JLR.
While
dietary fats that have short chains (such as those found in milk and
cheese products) can be absorbed directly into the bloodstream from the
intestines, long-chain fats need to be first packaged by the intestinal
cells into particles known as chylomicrons (large complexes similar to
HDL and LDL particles). Erik Eckhardt and colleagues at the University
of Kentucky wondered whether some unwanted LPS particles, routinely
shed by the bacteria that inhabit the human gut, might also be sneaking
in the chylomicrons.
Their hypothesis turned out to be
correct; when they treated cultured human intestinal cells with oleic
acid they observed significant secretion of LPS together with the
chylomicron particles, a phenomenon that was not observed when the
cells were treated with short-chain butyric acid. Similar findings were
found in mouse studies; high amounts of dietary oleic acid, but not
butyric acid, promoted significant absorption of LPS into the blood and
lymph nodes and subsequent expression of inflammatory genes.
Eckhardt
and colleagues believe these findings may pave the way for future
therapies for Crohn's disease and other inflammatory bowel disorders.
In addition, they note that this study once again highlights the
importance of the diverse bacteria that call our intestines home.
###
From the article: "Chylomicrons promote intestinal absorption of lipopolysaccharides" by
Sarbani Ghoshal, Jassir Witta, Jian Zhong, Willem de Villiers and Erik Eckhardt
Article link: http://www.jlr.org/cgi/content/full/50/1/90
Corresponding
Author: Erik Eckhardt, Department of Internal Medicine, University of
Kentucky, Lexington. Tel: 859 323 4933 * 81741; email: [email protected]
Note: This article also features a commentary available at http://www.jlr.org/cgi/content/full/50/1/1
The
American Society for Biochemistry and Molecular Biology is a nonprofit
scientific and educational organization with over 11,900 members in the
United States and internationally. Most members teach and conduct
research at colleges and universities. Others conduct research in
various government laboratories, nonprofit research institutions and
industry. The Society's student members attend undergraduate or
graduate institutions.
Founded in 1906, the Society is based
in Bethesda, Maryland, on the campus of the Federation of American
Societies for Experimental Biology. The Society's purpose is to advance
the science of biochemistry and molecular biology through publication
of the
Journal of Biological Chemistry, the
Journal of Lipid Research, and
Molecular and Cellular Proteomics,
organization of scientific meetings, advocacy for funding of basic
research and education, support of science education at all levels, and
promoting the diversity of individuals entering the scientific work
force.
For more information about ASBMB, see the Society's Web site at www.asbmb.org